In this context, a comprehensive understanding of the most effective strategies for preserving cognitive function in diabetic patients, particularly in relation to ADAM17's involvement in diabetes-associated MCI, necessitates continued investigation into these treatments and the development of targeted therapies. The gene discussed is ADAM17; the disease is diabetes mellitus.